Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxime Dehydration Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN107778279A offers safer Atorvastatin intermediate synthesis. Avoids toxic cyanide, ensures high purity, scalable for global supply chains.